ACH
NDRM

ArrowMark Colorado Holdings’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

ArrowMark Colorado Holdings’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-325,780
Closed -$12.7M – 361
2017
Q3 		$12.7M Buy
325,780
+46,225
+17% +$1.7M 0.14% 138
2017
Q2 		$8.36M Buy
279,555
+15,259
+6% +$395K 0.1% 167
2017
Q1 		$7.02M Sell
264,296
-53,115
-17% -$1.32M 0.1% 163
2016
Q4 		$7.05M Buy
317,411
+56,729
+22% +$1.06M 0.11% 153
2016
Q3 		$4.82M Buy
260,682
+82,079
+46% +$1.42M 0.09% 173
2016
Q2 		$2.9M Buy
178,603
+19,433
+12% +$327K 0.06% 177
2016
Q1 		$2.25M Buy
159,170
+28,198
+22% +$381K 0.05% 180
2015
Q4 		$2.23M Buy
130,972
+6,682
+5% +$130K 0.06% 183
2015
Q3 		$2.57M Buy
+124,290
New +$2.55M 0.07% 180

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

ArrowMark Colorado Holdings's NDRM Position: Q4 2017 in Review

ArrowMark Colorado Holdings sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 325,780 shares — an estimated $12.7M sold.

ArrowMark Colorado Holdings first reported a position in NDRM in Q3 2015 and held it in 9 quarters. The position peaked at $12.7M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • ArrowMark Colorado Holdings reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 325,780 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $12.7M.
  • ArrowMark Colorado Holdings first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 9 quarters.
  • ArrowMark Colorado Holdings's NeuroDerm Ltd. Ordinary Shares position peaked at $12.7M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.